The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
Premium- This morning Arrowhead Research (NASDAQ:ARWR) announced a $6.2MM direct offering of common stock and warrants. Shares will be sold to private investors, mostly current shareholders, … Continue Reading
Read now- Acorda Therapeutics (NASDAQ:ACOR) reported this morning that a 5mg dose of Ampyra was not as effective as the approved dose, Ampyra 10mg. The FDA required … Continue Reading
Read now- NPS Pharmaceuticals (NASDAQ:NPSP) announced this morning that the FDA delayed the action date for Gattex, an orphan drug treatment for Short Bowel Syndrome (SBS). The … Continue Reading
Read nowLong Ideas - This morning, PropThink featured an update on Ventrus Biosciences (NASDAQ: VTUS) post its second quarter results, noting that the company has enough cash to get … Continue Reading
Read now- Pfizer’s (NYSE:PFE) renal cell carcinoma treatment Torisel failed a study determining its capabilities in combination with Avastin. Torisel is approved as a monotherapy, but PFE … Continue Reading
Read now- After announcing an increased stock rebuyback program, Spectrum Pharmaceuticals (NASDAQ:SPPI) is up 4% this morning. SPPI’s board previously announced allowance for $25 million to repurchase … Continue Reading
Read nowLong Ideas - Ventrus Biosciences (NASDAQ:VTUS) released second quarter results last night, and notably, the company reported that it has $29 million in cash, enough to fund operations … Continue Reading
Read now
